identifying tp53 disruptions: a diagnostic measure in cll
Published 6 years ago • 375 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
2:27
the importance of tp53 & ighv testing before treatment initiation in cll
-
2:14
the importance of tp53 testing in cll
-
1:07
testing for ighv and tp53 mutations to guide treatment decisions in cll
-
1:38
the importance of tp53 in cll
-
1:37
the importance of genomic testing in the diagnosis of cll
-
23:00
examination of a hematological disease case
-
8:14
progress in the treatment of tp53 mutated aml
-
20:30
cll series #5 - what is a fish test?
-
2:02
the prognostic impact of tp53 and ighv status in the era of targeted therapies in cll
-
3:29
what are the best molecular diagnostic techniques in cll?
-
1:39
the importance of diagnostic testing in cll
-
0:54
re-testing in cll: fish analysis and tp53 screening
-
4:31
the impact of high and low burden tp53 mutations on risk and treatment decision in cll
-
2:49
assessing parameters and standardising biomarker detection in cll
-
1:26
the role of tp53 in cll
-
3:08
recent updates on tp53 mutation in cll
-
13:19
ighv and tp53 sequencing: clinical utility in chronic lymphocytic leukemia (cll)
-
1:38
the importance of targeting tp53 in aml and agents being explored
-
3:13
tp53 mutations in cll: a large retrospective analysis
-
17:52
diagnosis and initial treatment of cll
-
2:36
current knowledge of the tp53 mutation and its role in cll
-
3:14
understanding cll pathogenesis by assessing clonotypes